Jihua Group Corporation Limited(601718)
Financial statement report of 2021
Jihua Group Corporation Limited(601718) the balance sheet of the consolidated and parent company on December 31, 2021, the profit statement of the consolidated and parent company in 2021, the cash flow statement of the consolidated and parent company in 2021, the statement of changes in owner's equity of the consolidated and parent company in 2021 and the notes to relevant statements have been audited by Dahua Certified Public Accountants (special general partnership) and issued a standard unqualified audit report. The final accounts of the company in 2021 are reported as follows:
1、 Main accounting data in recent three years
Unit: 10000 yuan
Main accounting data 20212020 current period compared with the same period of last year 2019
Increase or decrease in current period (%)
Operating income 154940073149537160 3.61211535165
The deduction has nothing to do with the main business
Business income and lack of 151055845146384614 3.19/
After commercial real income
business income
Attributable to shareholders of listed companies -1656060 -7762385, not applicable to 626023
Net profit attributable to shareholders of listed companies
Deduction of non recurring profit and loss -3369492 -7630082 is not applicable to the net profit of -10087797
Net cash flow from operating activities 115217511481937 677.4818862081
Net assets attributable to shareholders of listed company 169145565170758958 -0.94179768096
Total assets 2829906463 Jinghua Pharmaceutical Group Co.Ltd(002349) 05 -5.74311974207
Main financial indicators: increase in 2021 and decrease in 2019 (%)
Basic earnings per share (yuan / -0.04 -0.18 - 0.01)
Shares)
Diluted earnings per share (yuan / -0.04 -0.18 - 0.01)
Shares)
After deducting non recurring profit and loss
Basic earnings per share (RMB -0.08 -0.18-0.23)
/ share)
The weighted average return on net assets was -0.97 -4.48, an increase of 3.51 percent and 0.35 percent
Rate (%) points
Increase by 2.42% after deducting non recurring profit and loss
Weighted average net assets closed -1.98 -4.40 points -5.61
Profit rate (%)
2、 Main operating results
1. Profit composition
In 2021, the total profit of the company was - 267 million yuan, an increase of 567 million yuan over 2020, and the operating profit was - 294 million yuan, an increase of 218 million yuan over 2020. The main reason is that compared with the same period last year, the production and operation profit in the reporting period increased year-on-year.
Detailed statement of profit composition in 2021
Monetary unit: 10000 yuan
Ratio of increase / decrease in 2021 to 2020 and ratio of increase / decrease in 2020
（%）
1、 Operating profit (loss expressed with "-")
1. Production and operation profit -745314 -33924422647128-
2. Income from changes in fair value -141502 -248190106688-
3. Asset impairment loss -214672 -16058401391168-
4. Credit impairment loss -3531698 -3170216 -361482-
Ratio of increase / decrease in 2021 to 2020 and ratio of increase / decrease in 2020
（%）
5. Investment income 110503552266 -441763 -79.99
6. Profit and loss from asset disposal 378.92914411 -876519 -95.86
7. Other income 15399621832957 -292995 -15.98
2、 Net non operating income and expenditure 277009 -32151123492121-
1. Non operating income 443437269208174229 64.72
2. Non operating expenses 1664283484320 -3317892 -95.22
3、 Total profit (loss expressed with "-")
Less: income tax expense 583422 -290.65612487-
4、 Net profit (net loss expressed with "-")
5、 Net profit attributable to owners of parent company -1656060 -7762385 - 6106325 -
2. Period cost
The cost in 2021 was 1402546400 yuan, a decrease of 9.68% over 1552810200 yuan in the previous year.
Detailed statement of cost composition in 2021
Monetary unit: 10000 yuan
Expense name amount of the current year and reason for change in proportion of amount in the previous period
（%）
It was mainly due to the impact of the epidemic on the development of relevant business activities in the same period of last year. Sales expenses 29769362574295 15.64 during the reporting period, the company increased the contracting of market orders, and the travel expenses, consulting fees and market development expenses increased year-on-year
The main reason is that the company strengthened the cost control, carried out three system reforms of management expenses 74260998332477 - 10.88, disposed of inefficient and invalid assets in the early stage, and the expenses of employee salary, depreciation, utilities and so on decreased year-on-year
Expense name amount of the current year and reason for change in proportion of amount in the previous period
（%）
It is the company and affiliated enterprises during the reporting period
Fully promote key scientific research of national ministries and commissions
R & D expenses 38381063100491 23.79 projects, military open research projects, etc
Implementation of a series of key scientific research projects
The investment of development funds increased year-on-year
The main reason is that the company continues to improve its capital profit
Use efficiency to increase capital concentration and "two
Financial expenses -2156761520839 -114.18 gold "management efforts, and the early disposal is low
Effective and ineffective assets improve the overall efficiency of funds
Revenue and financial expenses decreased year-on-year
Total 1402546415528102
